缩写名/全名 |
DRUGS R&D
DRUGS IN R&D |
||||||||||||||||
ISSN号 | 1174-5886 | ||||||||||||||||
研究方向 | Pharmacology, Toxicology and Pharmaceutics-Pharmacology | ||||||||||||||||
影响因子 | 2015:0, 2016:0, 2017:0, 2018:, 2019:2.277, | ||||||||||||||||
出版国家 | New Zealand | ||||||||||||||||
出版周期 | 4 issues a year, 2010- | ||||||||||||||||
年文章数 | 32 | ||||||||||||||||
出版年份 | 0 | ||||||||||||||||
是否OA | Yes | ||||||||||||||||
审稿周期(仅供参考) | |||||||||||||||||
录用比例 | |||||||||||||||||
投稿链接 | https://www.editorialmanager.com/drda/default.aspx | ||||||||||||||||
投稿官网 | http://link.springer.com/journal/40268 | ||||||||||||||||
h-index | 39 | ||||||||||||||||
CiteScore |
|
||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1174-5886%5BISSN%5D | ||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
中国学者近期发表的论文 | |
1. | Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension Author: Qi-Fang Huang, , Chang-Sheng Sheng, Yan Li, Gen-Shan Ma, Qiu-Yan Dai, Ji-Guang Wang Journal: Drugs in research & development, 2013, Vol.13, 109-117, DOI:10.1007/s40268-013-0013-9 DOI |
2. | Bioequivalence and Pharmacokinetic Evaluation of Two Formulations of Risperidone 2 mg Author: Yun Liu, Meng-qi Zhang, Jing-ying Jia, Yan-mei Liu, Gang-yi Liu, Shui-jun Li, Wei Wang, Li-ping Weng, Chen Yu Journal: Drugs in research & development, 2013, Vol.13, 29-36, DOI:10.1007/s40268-012-0002-4 DOI |
3. | Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension Author: Qi-Fang Huang, , Chang-Sheng Sheng, Yan Li, Gen-Shan Ma, Qiu-Yan Dai, Ji-Guang Wang Journal: Drugs in research & development, 2013, Vol.13, 109-117, DOI:10.1007/s40268-013-0013-9 DOI |
4. | Pharmacokinetics of Cefozopran by Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers Author: G. L. Wu, J. Z. Shentu, H. L. Zhou, M. X. Zhu, X. J. Hu, J. Liu, L. H. Wu Journal: Drugs in research & development, 2015, Vol.15, 63-70, DOI:10.1007/s40268-014-0075-3 DOI |
5. | A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus Author: Changyu Pan, Jorge L. Gross, Wenying Yang, Xiaofeng Lv, Li Sun, Charlotte Thim Hansen, Hongfei Xu, Robert Wagner Journal: Drugs in research & development, 2016, Vol.16, 239-249, DOI:10.1007/s40268-016-0134-z DOI |
|
|